Life

Health, science, climate, and society-focused reporting.

Billionaire's Initiative Aims to Enhance Scientific Research for AI Applications

Seemay Chou and Becky Pferdehirt propose a transformative approach through Radial, focusing on improving scientific methodologies to better serve AI development.

Editorial Staff Mar 11

Life

U.S. Health Spending Outpaces Other Nations but Growth Rate Lags

An analysis reveals that while the U.S. maintains the highest total health spending, eight OECD countries have surpassed it in per-person spending growth rates.

Editorial Staff Mar 11

Life

Impact of Reduced NIH Funding on Red States' Health Infrastructure

Recent reports indicate that states with Republican leadership are experiencing significant reductions in NIH funding, which may affect health outcomes and research capabilities.

Editorial Staff Mar 11

Life

Radial Nonprofit Launches with $500 Million to Enhance Scientific Processes for AI Integration

Radial, a new nonprofit organization, has secured at least $500 million in funding aimed at modernizing scientific processes to better accommodate artificial intelligence technologies.

Editorial Staff Mar 11

Life

Concerns Over AI Agent Validation in Health Care at HIMSS 2026

At HIMSS 2026, experts express concerns regarding the rapid deployment of AI agents in health care, highlighting the critical need for validation of these technologies.

Editorial Staff Mar 11

Life

Medical Education's Focus on Reactive Care Over Preventive Strategies

A medical student highlights the prevailing emphasis on reactive treatment in medical training, suggesting a need for greater focus on preventive care methodologies.

Editorial Staff Mar 11

Life

Boris Nikolic's Resurgence in Biotech Amid Controversy

Following the fallout from his association with Jeffrey Epstein, Boris Nikolic has managed to re-establish himself in the biotech sector, aided by strategic partnerships.

Editorial Staff Mar 11

Life

Impact of Healthcare Costs on Access: A Data-Driven Analysis

This analysis utilizes National Health Interview Survey data to examine how healthcare costs influence access to care in the U.S. through 2024.

Editorial Staff Mar 10

Life

Sen. Johnson Questions FDA's Drug Approval Process for Rare Diseases

Senator Ron Johnson is scrutinizing the FDA's rejection of treatments for rare diseases, following a discussion with Commissioner Marty Makary that raised significant concerns.

Editorial Staff Mar 10

Life

Analysis of RFK Jr.'s MAHA Coalition's Vaccine Policy Discussions

A recent gathering of RFK Jr.'s allies focused on vaccine policy, with minimal reference to the health secretary, raising questions about the coalition's strategic direction.

Editorial Staff Mar 10

Life

FDA Approves Leucovorin for Rare Brain Disorder, Rejects Autism Treatment Claims

The FDA has approved leucovorin for a rare brain disorder but has clarified that there is no evidence to support its use as a treatment for autism, countering previous assertions.

Editorial Staff Mar 10

Life

FDA Issues Warning to Novo Nordisk Over Reporting Failures

The FDA has issued a warning to Novo Nordisk for not reporting side effects, marking the third such admonition in recent weeks for various practices.

Editorial Staff Mar 10

Life

FDA Issues Third Warning to Novo Nordisk Over GLP-1 Drug Reporting Failures

The FDA's recent warning to Novo Nordisk highlights ongoing concerns regarding the company's reporting practices for GLP-1 drugs, particularly related to potential side effects.

Editorial Staff Mar 10

Life

Nabla to Leverage Technology from AMI Following $1 Billion Funding Round

Nabla, an AI scribe company, is set to enhance its capabilities by integrating technology from Yann LeCun's AMI, which has secured $1 billion in funding.

Editorial Staff Mar 10

Life

Senator Investigates FDA as BioNTech Founders Depart for New Venture

The co-founders of BioNTech are leaving to establish a new mRNA-focused company, prompting a U.S. senator to investigate the FDA's oversight.

Editorial Staff Mar 10

Life

HHS Cancels Autism Meetings, Impacting Health Infrastructure Discussions

The cancellation of autism meetings by HHS raises concerns about ongoing health infrastructure developments, including epilepsy medication responses and kidney transplant system reforms.

Editorial Staff Mar 10

Life

Oral Contraceptive Pills: Access and Availability Overview

This brief examines the access and availability of oral contraceptives, focusing on insurance coverage and strategies for enhancing women's healthcare access.

Editorial Staff Mar 10

Life

BioNTech Founders Transition to New mRNA-Focused Venture

Ugur Sahin and Özlem Türeci, co-founders of BioNTech, are departing to establish a new company centered on mRNA technology, signaling a shift in their strategic focus.

Editorial Staff Mar 10

Life

Significant Decline in Antibiotic Development by Major Drugmakers

A recent analysis indicates that the world’s largest pharmaceutical companies have reduced their antibiotic development efforts by 35% over the last five years, raising concerns about future antimicrobial capacity.

Editorial Staff Mar 10

Life

Significant Decline in Antibiotic Development by Major Drugmakers

A recent analysis reveals a 35% reduction in potential antimicrobial treatments from leading pharmaceutical companies over the last five years, raising concerns about future capacity.

Editorial Staff Mar 10